Sort   by:  
 Page size 
UnknownVaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination Immunotherapy.
Not available
S-EPMC7956439 | biostudies-literature
UnknownInhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
Not available
S-EPMC7073293 | biostudies-literature
UnknownSingle-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast.
Not available
S-EPMC8373912 | biostudies-literature
UnknownCombined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC.
Not available
S-EPMC8758507 | biostudies-literature
UnknownCXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth.
Not available
S-EPMC10239119 | biostudies-literature
UnknownNeutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC.
Not available
S-EPMC6975266 | biostudies-literature
UnknownTargeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer.
Not available
S-EPMC9925045 | biostudies-literature
UnknownKRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer.
Not available
S-EPMC6467776 | biostudies-literature
Sort   by:  
 Page size